News

Courtney Caputo Takes Leadership Role at Epilepsy Foundation

Courtney Caputo Takes Leadership Role at Epilepsy Foundation

Courtney Caputo Appointed as Chair of the National Board

The Epilepsy Foundation of America is excited to announce Courtney Caputo's appointment as Chair of the National Board of Directors. Her journey with epilepsy and extensive experience in advocacy make her a perfect fit for this critical role at a pivotal moment for the Foundation.

Caputo's Advocacy Work and Personal Connection

Caputo has been a steadfast advocate for the epilepsy community for many years. She founded "Team Super T", a leading fundraising team for walks dedicated to raising awareness and support for epilepsy. This initiative is named in honor of her daughter, who also lives with the condition. Additionally, Caputo serves as Chair of the National Epilepsy Walk and has previously occupied various leadership positions within the Foundation, including Vice Chair.

Impact on National Advocacy

Her advocacy is rooted in personal experience, as she deeply understands the complexities of epilepsy. "What inspired me to become an advocate is the complexity of this disease," Caputo shared. "It is my mission to be a guiding resource for families facing the everyday challenges of epilepsy."

Professional Background

In her professional sphere, Caputo is the Senior Vice President of Global Government Relations at Parsons Corporation. In this position, she effectively represents the interests of 19,000 employees and oversees operations generating more than $5 billion in revenue each year, supporting defense and critical infrastructure initiatives. Her leadership has resulted in significant business growth, with more than $250 million driven yearly in various sectors.

Previous Experience

Her career also includes pivotal roles at Raytheon Technologies, where she played a crucial part in business development and government relations. Caputo's expertise was honed through her strategic consulting at Michael E. Dunn & Associates, and her public policy work at Deloitte. She also has congressional experience working with a U.S. Representative.

Foundation Priorities Under Caputo's Leadership

Caputo's vision for her term as Chair includes a strong focus on enhancing education, policy reform, research funding, and combatting stigma associated with epilepsy. She emphasized the importance of building relationships to strengthen research and medical funding, saying, "It’s an honor to lead the Board in this crucial work for all families affected by epilepsy."

About Epilepsy

With nearly 3.4 million Americans affected by epilepsy, the condition is recognized as the most prevalent chronic brain disorder globally. It is characterized by recurring seizures, which arise from sudden electrical disruptions in the brain, leading to various behavioral, awareness, and bodily control challenges. The impacts of epilepsy extend beyond the seizures themselves, negatively affecting memory, mood, and concentration.

About the Epilepsy Foundation of America

The Epilepsy Foundation is a dedicated nonprofit organization devoted to improving the lives of people touched by epilepsy through education, advocacy, and funding. With over five decades of commitment, the Foundation focuses on raising awareness, reducing stigma, and supporting strategies that facilitate significant advancements for those living with epilepsy. Their mission includes funding innovative research and supporting new investigators working on treatments and therapies. The Foundation also enhances access to care and training in seizure recognition.

Get in Touch with the Foundation

If you wish to learn more, please contact Kaitlyn Gallagher at 301.918.3756 or via email at kgallagher@efa.org.

Frequently Asked Questions

Who is Courtney Caputo?

Courtney Caputo is the newly appointed Chair of the National Board of Directors for the Epilepsy Foundation of America and an advocate for the epilepsy community.

What does her role involve?

As Chair, Caputo will lead the Board in strategic initiatives focused on education, policy reform, research funding, and stigma reduction.

What is Team Super T?

Team Super T is a fundraising team dedicated to supporting epilepsy initiatives, founded by Caputo in honor of her daughter living with epilepsy.

How can I contact the Epilepsy Foundation?

You can reach out through the provided media contact, Kaitlyn Gallagher, at 301.918.3756 or via email at kgallagher@efa.org.

What is the mission of the Epilepsy Foundation?

The Foundation is committed to improving the lives of those affected by epilepsy through education, research, and advocacy efforts.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 27

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 182

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 110

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 247

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 116

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 0

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 197

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

b1BANK Partners with Spiral to Enhance Community Banking Impact

Updated Category News Views 97

Enhanced Financial Wellness through Partnership NEW YORK--Today, Spiral, a personalized banking platform, announced a significant partnership with b1BANK, established as a community-focused banking institution. Through this collaboration, the two organizations aim to enhance financial wellness for customers, leveraging b1BANK's dedication to innovative banking solutions...

Continue Reading
AM Best Explores Trends Influencing For-Hire Trucking Industry

Updated Category News Views 168

Insights from AM Best's Latest Webinar on Trucking Trends Viewers can now delve into the highlights from the enlightening webinar hosted by AM Best, titled "For-Hire Trucking: The Risky Road Ahead." This event focused on the intricacies and challenges within the transportation-for-hire trucking sector, providing expert insights into risk management strategies and the...

Continue Reading
BitMart's Creative Campaign to Ignite Offline Crypto Engagement

Updated Category News Views 135

Introducing the Fox Hunt Delivery Campaign BitMart, a leading global cryptocurrency exchange, is excited to announce the launch of the Fox Hunt Delivery Campaign, a unique initiative aimed at boosting cryptocurrency adoption through engaging offline activities. This campaign offers an exciting chance for participants to earn USDT rewards simply by introducing new users to...

Continue Reading
Trinity Capital Inc. Fuels Alt Platform's Growth with $40M Credit

Updated Category News Views 273

Trinity Capital Inc. Supports Alt with Significant Credit Facility Trinity Capital Inc. (NASDAQ: TRIN), a prominent alternative asset manager, is thrilled to announce a groundbreaking agreement with Alt, providing up to $40 million through an asset-based revolving credit facility. This funding aims to bolster Alt's innovative marketplace tailored for trading card...

Continue Reading
Everest Medicines Achieves Record Revenue and Growth in 2024

Updated Category News Views 506

Everest Medicines Achieves Remarkable Financial Success Everest Medicines, a groundbreaking biopharmaceutical company focused on innovative healthcare solutions, has reported remarkable financial results for the year ending December 31, 2024. With a robust revenue growth of 461%, the company stands out in the pharmaceutical industry, showcasing its resilience and dynamic...

Continue Reading